James A. McNulty

Insider Reports History

Location
Las Vegas, NV
Signature
/s/ James A. McNulty
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James A. McNulty:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inhibitor Therapeutics, Inc. Chief Financial Officer Common Stock 1,946,135 02 Dec 2024 Direct
RENOVARO INC. Director Option to purchase shares of common stock 120,968 04 Nov 2024 Direct
Inhibitor Therapeutics, Inc. Chief Financial Officer Stock Option 100,000 16 Mar 2024 Direct

Insider Reports Filed by James A. McNulty

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INTI Inhibitor Therapeutics, Inc. 31 Dec 2024 1 $0 5 Chief Financial Officer 19 Feb 2025, 21:28
RENB RENOVARO INC. 04 Nov 2024 1 $0 4 Director 06 Nov 2024, 15:25
RENB RENOVARO INC. 14 Oct 2024 0 $0 3 Director 23 Oct 2024, 12:33
INTI Inhibitor Therapeutics, Inc. 16 Mar 2024 1 $0 4 CHIEF FINANCIAL OFFICER, 10%+ Owner 16 May 2024, 13:34
INTI Inhibitor Therapeutics, Inc. 05 May 2023 3 $0 4 Chief Financial Officer, Treasurer, Secretary of the Company, 10%+ Owner 17 May 2023, 19:46
INTI Inhibitor Therapeutics, Inc. 13 Dec 2022 0 $0 3 Chief Financial Officer, Treasurer, Secretary of the Company, 10%+ Owner 22 Dec 2022, 20:31